Skip to main content
. 2020 Sep 16;39(2):469–476. doi: 10.1007/s10637-020-01001-5

Fig. 2.

Fig. 2

Plasma crenigacestat concentration-time profiles in Japanese patients with solid tumors. Mean (±SD) plasma concentration-time profiles on days 1 and 22 during the first cycle following thrice weekly oral doses of 25 mg or 50 mg of crenigacestat in Japanese patients with solid tumors. Abbreviations: hr, hour; n, number of patients; SD, standard deviation